3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Parotid Neoplasms
1
Neoplasm Metastasis
1
Colonic Polyps
1
Colonic Neoplasms
1
Interventions
Rocuronium
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
ziprasidone
1
venetoclax
1
saponin QA-21V1
1
perflutren
1
finerenone
1
empagliflozin
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Thalidomide
1
Surveys and Questionnaires
1
Stem Cell Transplantation
1
Spironolactone
1
Specimen Handling
1
Simethicone
1
Sevelamer
1
Resistance Training
1
Quillaja Saponins
1
Protein Subunit Vaccines
1
Polymorphism, Genetic
1
Piperacillin, Tazobactam Drug Combination
1
Phlebotomy
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Renal Insufficiency, Chronic
×
Citric Acid
×
Clear all
NCT04709770
2021-01-14
PrepDial
University of Bari
Phase 4
Unknown
264 enrolled